Jefferies Group’s Encompass Health EHC Stock Holding History

Jefferies Group’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-276,540	Closed	-$7.59M	–	1985
2013 Q3	$7.59M	Hold	276,540	–	–	0.07%	238
2013 Q2	$6.34M	Buy	+276,540	New	+$6.25M	0.07%	210

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's EHC Position: Q4 2021 in Review

Jefferies Group sold out of Encompass Health (EHC) in Q4 2021, closing a stake of 6,383 shares — an estimated $381K sold.

Jefferies Group first reported a position in EHC in Q2 2013 and held it in 22 quarters. The position peaked at $4.89M in Q3 2018. 409 funds tracked by Wall St. Rank hold EHC as of Q4 2021.

Jefferies Group reported no remaining Encompass Health position as of Q4 2021 after selling out during the quarter.
Jefferies Group sold 6,383 Encompass Health shares in Q4 2021, an estimated $381K.
Jefferies Group first reported a position in Encompass Health in Q2 2013 and held it in 22 quarters.
Jefferies Group's Encompass Health position peaked at $4.89M in Q3 2018.
409 funds tracked by Wall St. Rank held Encompass Health as of Q4 2021.

Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.